Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Tissue Heart Valves Market Poised To Hit $1.72 Billion By 2030 With A 2.5% CAGR#_x000D_
The market size for tissue heart valves has experienced consistent growth in recent years. It is projected to increase from $1.52 billion in 2025 to $1.56 billion by 2026, displaying a compound annual growth rate (CAGR) of 2.6%. Historically, this growth can be attributed to the rise in cardiovascular diseases, the limitations associated with mechanical valves, the increasing adoption of surgical valve replacement procedures, advancements in hospital cardiac infrastructure, and the expanding aging demographic._x000D_
_x000D_
The tissue heart valves market is anticipated to observe consistent expansion over the upcoming years. It is predicted to attain a size of $1.72 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 2.5%. The projected increase during this period stems from factors such as the expansion of TAVR procedures, the rise in minimally invasive cardiac surgeries, advancements in valve durability, greater access to healthcare, and the growth in cardiology specialization. Key trends expected in the forecast period encompass a rising preference for bioprosthetic valves, an increase in transcatheter valve procedures, enhancements in tissue preservation methods, a decrease in the necessity for long-term anticoagulation, and the demand for valve replacement driven by an aging demographic._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Tissue Heart Valves Market Growth Momentum: What Factors Are Shaping Demand?#_x000D_
The increasing prevalence of cardiovascular diseases is expected to propel the growth of the tissue heart valves market going forward. Cardiovascular diseases (CVDs) refer to a group of disorders affecting the heart and blood vessels, including conditions such as heart attacks, strokes, and hypertension. The increasing prevalence of cardiovascular diseases (CVDs) is primarily driven by factors such as unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, leading to higher rates of heart-related disorders globally. Tissue heart valves are crucial in addressing cardiovascular diseases (CVDs) by providing a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, improving long-term heart function, and reducing the risk of complications. For instance, in September 2024, according to a report published by the Heart Failure Society of America (HFSA), a US-based professional organization company, approximately 6.7 million Americans aged 20 and older are currently living with heart failure (HF), with projections indicating this number will increase to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050 respectively. Therefore, the increasing prevalence of cardiovascular diseases drives the growth of the tissue heart valve market._x000D_
_x000D_
#Tissue Heart Valves Market Breakdown By Product Type And Application#_x000D_
The tissue heart valves market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves_x000D_
2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR)_x000D_
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves _x000D_
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves_x000D_
_x000D_
#Tissue Heart Valves Market Trends Redefining Industry Growth#_x000D_
Major companies in the tissue heart valves market are concentrating on developing innovative products, such as surgical aortic tissue valves, to simplify their use during implantation and manage patients throughout their lives. A surgical aortic tissue valve is a prosthetic heart valve crafted from biological tissue, typically utilized to replace a diseased or damaged aortic valve in cardiac surgery. For instance, in June 2024, Medtronic plc., an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to improve ease of use during implantation and support long-term patient care. Building on 10 years of clinical experience with the Avalus valve, it features a low valve profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to enhance blood flow. The valve also includes a radiopaque coil for clear visibility in future valve-in-valve procedures, offering extended durability for patients with aortic stenosis._x000D_
_x000D_
#Tissue Heart Valves Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co. _x000D_
_x000D_
#View The Full Tissue Heart Valves Market Report:#_x000D_
_x000D_
#Tissue Heart Valves Market Largest Region: Which Geography Holds The Highest Market Share?#_x000D_
North America was the largest region in the tissue heart valves market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.